Loading clinical trials...
Loading clinical trials...
The Effect of Neural Mobilization Exercise on Lower Limb Pain in Patients With Rheumatoid Arthritis.
This clinical trial is the first study to apply neurodynamic mobilization, a nervous system specific therapeutic exercise, on patients with rheumatoid arthritis(RA). Objective of the study is to find out the effect of neurodynamic mobilization for joint inflammation in patients with RA.
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by generalized joints inflammation. With increasing investigation on the pathology, the treatment focus on the conditions shifted from a musculoskeletal point of view to a systemic approach. The awareness of holistic treatment was also increased. Latest studies have found out the neurogenic inflammatory mechanism played an important role in the inflammatory process of RA, the pathological changes of neural tissues in RA were also noted. This clinical trial is the first study to apply neurodynamic mobilization, a nervous system specific therapeutic exercise, on patients with RA. Objective of the study is to find out the effect of neurodynamic mobilization for joint inflammation in patients with RA. Population Adults who are diagnosed with Rheumatoid Arthritis. Intervention Neurodynamic Exercise Comparison Standard conservative physiotherapy protocol Outcome Rheumatoid Arthritis Pain Scale (RAPS) C-reactive protein (CRP) test
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
The Hong Kong Polytechnic University
Hong Kong, Hong Kong
Start Date
August 1, 2015
Primary Completion Date
August 1, 2016
Completion Date
August 1, 2016
Last Updated
February 25, 2016
40
ESTIMATED participants
Neurodynamic mobilization exercise
OTHER
Conservative Physiotherapy
OTHER
Lead Sponsor
The Hong Kong Polytechnic University
NCT06647069
NCT07484243
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions